Table 2.

Early CAR T-cell toxicity

Early CAR T-cell toxicity	CAR T-cell patients N = 280
CRS diagnosis, n (%)	239 (85)
CRS grade, n (%)
1	102 (43)
2	125 (52)
3	8 (3)
4	4 (2)
Days to maximum grade CRS, median (range)	5 (0-12)
Tocilizumab for CRS, n (%)	180 (75)
Tocilizumab doses, median (range)	2 (1-4)
Corticosteroids for CRS, n (%)	118 (49)
ICANS diagnosis, n (%)	153 (55)
Days to onset, median (range)	6 (0-34)
ICANS grade, n (%)
1	33 (22)
2	34 (22)
3	86 (56)
Corticosteroids for ICANS, n (%)	103 (67)